121 related articles for article (PubMed ID: 9141543)
1. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.
Boguszewski CL; Johannsson G; Bengtsson BA; Johansson A; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1997 May; 82(5):1516-21. PubMed ID: 9141543
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
3. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM
J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
[TBL] [Abstract][Full Text] [Related]
6. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
7. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
8. Twenty-kilodalton human growth hormone (20K hGH) secretion from growth hormone-secreting pituitary adenoma cells in vitro.
Murakami Y; Mori T; Koshimura K; Kurosaki M; Takenobu A; Hashimoto Y; Kato Y
Endocr J; 2000 Oct; 47(5):563-8. PubMed ID: 11200936
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of 20 kilodalton human growth hormone (20K-hGH) in patients with acromegaly before and after treatment with octreotide and transsphenoidal surgery.
Murakami Y; Shimizu T; Yamamoto M; Kato Y
Endocr J; 2004 Jun; 51(3):343-8. PubMed ID: 15256780
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
[TBL] [Abstract][Full Text] [Related]
12. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
14. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
[TBL] [Abstract][Full Text] [Related]
15. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
16. 22-kD growth hormone exclusion assay: a new approach to measurement of non-22-kD growth hormone isoforms in human blood.
Boguszewski CL; Hynsjö L; Johannsson G; Bengtsson BA; Carlsson LM
Eur J Endocrinol; 1996 Nov; 135(5):573-82. PubMed ID: 8980160
[TBL] [Abstract][Full Text] [Related]
17. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
[TBL] [Abstract][Full Text] [Related]
20. Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects.
Coya R; Algorta J; Boguszewski CL; Vela A; Carlsson LM; Aniel-Quiroga A; Busturia MA; Martul P
Growth Horm IGF Res; 2005 Apr; 15(2):123-9. PubMed ID: 15809015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
